*** Welcome to piglix ***

Lundbeck

H. Lundbeck A/S
Publicly traded Aktieselskab
Traded as Nasdaq CopenhagenLUN
Industry Pharmaceuticals
Founded 1915
Headquarters Copenhagen, Denmark
Key people
Håkan Björklund (Chairman), Kåre Schultz (CEO - May 2015 - present)
Revenue DKK 15.2 billion (2013)
DKK 1.6 billion (2013)
Profit DKK 855 million (2013)
Total assets DKK 23.7 billion (end 2013)
Total equity DKK 13.5 billion (end 2013)
Number of employees
5,530 (average, 2013)
Website lundbeck.com

H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia.

Headquartered in Copenhagen, Denmark, Lundbeck has international production facilities in Denmark, Italy and France and affiliates or sales offices in 57 countries. Lundbeck employs around 5.500 people globally (as of 2013), and the company’s products are registered in more than 100 countries worldwide.

In 2013, the company's revenue was DKK 15.2 billion (€2.04 billion).

Lundbeck is listed on the (CSE).

Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)

The company was founded by Hans Lundbeck in 1915, and was initially a trading company supplying a variety of goods to the Danish market, including machinery for manufacturing, aluminium foil, artificial sweeteners, and photographic equipment.

Lundbeck entered the pharmaceutical market in 1924, importing medicines and cosmetics from companies based in other European and American countries. By the late 1930s, Lundbeck had begun to produce its own medicinal products and had established its own research department. Production continued during the Second World War, although it was limited due to a lack of raw materials.


...
Wikipedia

...